azacitidine,cladribine,venetoclax,enasidenib
bms,Merck,roche,abbvie,Servier
['aza ', 'enasidenib', '#mpn', 'leusm', 'venetoclax', 'rova,(-approval)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'rova,(-approval),(-microvascular)', 'mpnsm', 'cladribine', 'mds', 'novo ']
and talk 3 by on mpn-ap/bp #ash22 #mpnsm #leusm
-rates of progression to mpn-bp
-poor prognosis in mpn-bp
-responses to novel treatment approaches (including our work on idh2 inhib 
Asst Prof & Director Inpatient Leukemia Service @UChicagoMed. @NorthwesternU @Mumedicine @NU_IntMed @UCHemOncFellows alum. tweets=mine. RT?endorsement. He/him